OraLiva
PrivateLast Round
Seed
Sep 22, 2025
Total Funding Raised
$5.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OraLiva is a diagnostic equipment company that has developed an AI-powered cytology platform for the early detection of oral cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OraLiva Comparables
Compare OraLiva with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The Procter & Gamble Company | 66% | |
| Colgate-Palmolive Co. | 65% | |
| Viome Life Sciences, Inc. | 49% |
OraLiva Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 22, 2025 | ||||
| Grant | Aug 15, 2025 | ||||
| Grant | Jul 10, 2025 |
OraLiva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant, Seed |
| NIH RADx | Grant |
| RTP Angel Fund | Seed |
| New York University | Seed |
| National Institute of Dental and Craniofacial Research | Grant, Seed |
| NYU Innovation Venture Fund | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
Launched a new oral cancer test.
- Sep 22, 2025
Launching AI-powered cytology platform for early oral cancer diagnosis.
OraLiva Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OraLiva's valuation, stock price, and market status.
Is OraLiva a public or private company?
OraLiva is a private company.
What is the current stock price of OraLiva?
OraLiva is a private company with no public stock price. No recent secondary market data is available.
How much is OraLiva worth (valuation)?
Valuation information for OraLiva is not publicly available.
Can I buy OraLiva stock?
OraLiva shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OraLiva's last funding round?
OraLiva's most recent funding round was Seed on October 6, 2025.
Who are the main investors in OraLiva?
Key investors in OraLiva include National Cancer Institute, NIH RADx, RTP Angel Fund, National Institute of Dental and Craniofacial Research, NYU Innovation Venture Fund.
Will OraLiva IPO soon?
No public IPO plans have been announced for OraLiva.
How can I track OraLiva secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OraLiva's secondary market activity and sign up for updates.